Meeting Report
Treating Venous Thrombosis in Oncology
Presented by Rowena Schwartz, PharmD, BCOP
University of Cincinnati, Cincinnati, Ohio
Presenter’s disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2019;10(3):230–232 |
https://doi.org/10.6004/jadpro.2019.10.3.5 |
© 2019 Harborside™
ABSTRACT
According to Rowena Schwartz, PharmD, BCOP, it is important to consider broad treatment options, both direct oral anticoagulants and older agents such as heparin, when treating patients with venous thromboembolism, as the newer agents may not be for everyone. Dr. Schwartz also reviewed how to monitor and assess patient response to anticoagulant treatment.
For access to the full length article, please
sign in.
